Innovation1 Biotech EBIT

Innovation1 Biotech (IVBT) currently reports a EBIT of $-4.8M as of February 2024. That compares with $-40M in the prior-year period — up 87.9% year over year. That is below the sector sector average of $2.5T. Use the charts on this page to explore Innovation1 Biotech's EBIT history and peer comparisons.

Innovation1 Biotech's EBIT increased from $-40M to $-4.8M — a 87.9% year-over-year increase (period ending February 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Innovation1 Biotech's EBIT of $-4.8M is lower than the its sector sector average of $2.5T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Innovation1 Biotech reported $-4.8M in EBIT as of February 2024. That compares with $-40M in the prior-year period — up 87.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-4.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $2.5T. From there, open related valuation or income-statement pages for Innovation1 Biotech, and consider following IVBT for alerts when major investors trade the stock.